Pacira Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
24.09.24
/
50%
€12.60
Target price
24.09.25
€16.13
Performance (%)
11.90%
Price
03.10.24
€14.10
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ currently has a performance of 11.90%. This prediction currently runs until 24.09.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Pacira Pharmaceuticals | 9.302% |
iShares Core DAX® | -1.114% |
iShares Nasdaq 100 | 1.816% |
iShares Nikkei 225® | 2.113% |
iShares S&P 500 | 2.038% |
Comments by Jefferies_Financial_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat